Home LiteratureArticle Details
PMID: 9873017 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Tumor necrosis factor-alpha-inducible IkappaBalpha proteolysis mediated by cytosolic m-calpain. A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-kappab activation.

The Journal of biological chemistry ·Vol. 274 ·No. 2 ·1999-01-08 ·Pages 787-94

Han Y, Weinman S, Boldogh I, Walker RK, Brasier AR

Abstract

The cytokine tumor necrosis factor alpha (TNF-alpha) induces expression of inflammatory gene networks by activating cytoplasmic to nuclear translocation of the nuclear factor-kappaB (NF-kappaB) transcription factor. NF-kappaB activation results from sequential phosphorylation and hydrolysis of the cytoplasmic inhibitor, IkappaBalpha, through the 26 S proteasome. Here, we show a parallel proteasome-independent pathway for cytokine-inducible IkappaBalpha proteolysis in HepG2 liver cells mediated by cytosolic calcium-activated neutral protease (calpains). Pretreatment with either calpain- or proteasome-selective inhibitors partially blocks up to 50% of TNF-alpha-inducible IkappaBalpha proteolysis; pretreatment with both is required to completely block IkappaBalpha proteolysis. Similarly, in transient cotransfection assays, expression of the specific inhibitor, calpastatin, partially blocks TNF-alpha-inducible NF-kappaB-dependent promoter activity and IkappaBalpha proteolysis. In TNF-alpha-stimulated cells, a rapid (within 1 min), 2.2-fold increase in cytosolic calpain proteolytic activity is measured using a specific fluorescent assay. Inducible calpain proteolytic activity occurs coincidentally with the particulate-to-cytosol redistribution of the catalytic m-calpain subunit into the IkappaBalpha compartment. Addition of catalytically active m-calpain into broken cells was sufficient to produce ligand-independent IkappaBalpha proteolysis and NF-kappaB translocation. As additional evidence for calpain-dependent IkappaBalpha proteolysis and NF-kappaB activation, we demonstrate that this process occurs in a cell line (ts20b) deficient in the ubiquitin-proteasome pathway. Following inactivation of the temperature-sensitive ubiquitin-activating enzyme, IkappaBalpha proteolysis occurs in a manner sensitive only to calpain inhibitors. Our results demonstrate that TNF-alpha activates cytosolic calpains, a parallel pathway that degrades IkappaBalpha and activates NF-kappaB activation independently of the ubiquitin-proteasome pathway.

MeSH Terms
Base Sequence Biological Transport Calpain/antagonists & inhibitors,metabolism Cell Line Cysteine Endopeptidases/metabolism Cysteine Proteinase Inhibitors/metabolism Cytosol/metabolism DNA Primers DNA-Binding Proteins/metabolism Humans Hydrolysis I-kappa B Proteins Multienzyme Complexes/metabolism NF-KappaB Inhibitor alpha NF-kappa B/metabolism Proteasome Endopeptidase Complex Substrate Specificity Tumor Necrosis Factor-alpha/metabolism Ubiquitins/metabolism
Chemicals
Cysteine Proteinase Inhibitors DNA Primers DNA-Binding Proteins I-kappa B Proteins Multienzyme Complexes NF-kappa B NFKBIA protein, human Tumor Necrosis Factor-alpha Ubiquitins NF-KappaB Inhibitor alpha Calpain Cysteine Endopeptidases Proteasome Endopeptidase Complex
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Han Y
Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas 77555-1060, USA.
Weinman S
Boldogh I
Walker R K
Brasier A R
Article Info
Journal
The Journal of biological chemistry
Abbr.
J Biol Chem
ISSN
0021-9258
Published
1999-01-08
Pages
787-94
Language
English
Region
United States
NLM ID
2985121R
Subset
IM
Grants
NHLBI NIH HHS · NHLBI55630 · United States
NIEHS NIH HHS · P30ES06676 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com